Life Sciences IPOs Take a Breather December 02, 2013 | Press Release
Booming IPO Market Improving M&A Terms for Private Biotechs November 01, 2013 | Press Release
ADMA Biologics, Inc. Announces Pricing October 18, 2013 | Press ReleaseSee all News
In addition to acting as an agent and advisor for its clients, the Burrill Merchant Banking group oversees an active portfolio of stakes in public and late-stage private life sciences companies. In its investment activities, the Burrill Merchant Banking group is able to leverage its significant transactional experience and deep scientific expertise. These investments include, but not exclusively, investment interests in Burrill Merchant Banking clients. In addition, private equity investments can be structured as bridge financings to larger transactions, allowing a company to meet near-term milestones without the need for a fully-marketed transaction.